Overview

Liposomal Bupivacaine vs Ropivacaine for TAPBs

Status:
RECRUITING
Trial end date:
2024-06-01
Target enrollment:
Participant gender:
Summary
Few studies have compared the efficacy of ultrasound (US)-guided TAP blocks with Liposomal bupivacaine(LB) versus ropivacaine in reducing postoperative opioid usage in patients undergoing laparoscopic lower abdominal tumor Resection. Therefore, we are conducting this prospective, randomized controlled trial to compare the postoperative analgesic effects of LB and ropivacaine for TAP blocks among patients undergoing laparoscopic colorectal procedures.
Phase:
PHASE3
Details
Lead Sponsor:
Sun Yat-sen University
Treatments:
Ropivacaine